HeartBeam Partners with HeartNexus to Expand Remote Cardiac Monitoring Services

HeartBeam Inc. (NASDAQ: BEAT) has announced a strategic partnership with HeartNexus Inc., a network of board-certified cardiologists specializing in cardiac test interpretation, peer consultations, and telemedicine visits. This collaboration enables HeartBeam to offer 24/7 cardiology reader services for patients experiencing cardiac symptoms outside traditional care settings, marking a significant advancement in remote cardiac monitoring capabilities. The partnership leverages HeartBeam's patented 3D technology that allows patients to capture 30-second, cable-free ECG recordings whenever symptoms occur and transmit the data directly to HeartNexus cardiologists for immediate interpretation.

The integration of HeartNexus's specialized cardiology services with HeartBeam's innovative technology platform creates a comprehensive ecosystem for remote cardiac care. Robert Eno, CEO of HeartBeam, emphasized that working with HeartNexus accelerates the company's mission to make medical-grade cardiac monitoring accessible beyond the walls of medical facilities. This partnership represents a crucial step in addressing the growing need for timely cardiac assessment, particularly for patients who experience symptoms outside regular clinical hours or in non-traditional settings.

HeartBeam's technology platform is creating the first-ever cable-free device capable of collecting ECG signals in three dimensions from three non-coplanar directions and synthesizing these signals into a 12-lead ECG. This innovative approach to cardiac monitoring received FDA clearance for arrhythmia assessment in December 2024, while the 12-Lead ECG synthesis software remains under FDA review. The company's extensive intellectual property portfolio includes over 20 issued patents related to technology enablement, providing a strong foundation for future developments in remote cardiac care.

The collaboration with HeartNexus not only provides immediate cardiology interpretation services but also lays the groundwork for future integration of AI wellness features and wearable technology enhancements. This expansion of HeartBeam's service offerings could significantly impact how cardiac conditions are detected and monitored in ambulatory settings. Physicians using this integrated system will be able to identify cardiac health trends and acute conditions while directing patients to appropriate care outside traditional medical facilities, potentially reducing emergency room visits and hospital admissions for non-critical cardiac events.

For additional information about HeartBeam's developments, investors can access the company's newsroom at https://ibn.fm/BEAT. The full details of the partnership announcement are available in the complete press release at https://ibn.fm/HqwuQ. This partnership represents a meaningful advancement in telemedicine and remote patient monitoring, addressing critical gaps in cardiac care accessibility and timely intervention.